Companion Diagnostics
Companion diagnostics are specialized tests that identify patients most likely to benefit from
specific treatments, ensuring personalized and effective therapy. These diagnostics can detect
genetic mutations or biomarkers and determine drug susceptibility in pathogens for individual
patients. By aligning treatments with individual patient profiles, companion diagnostics enhance
the precision, efficacy and cost-effectiveness of medical interventions. Demonstrating the value
of companion diagnostics can be challenging as the primary benefit lies in ensuring that expensive
therapies are only given to patients most likely to respond, which translates to significant cost
savings and improved outcomes over time. Yet, these benefits are not always immediately apparent,
making it difficult to justify the initial investment to doctors, insurers, and other
stakeholders.
Our solutions can be applied to multiple disease areas. We currently focus on oncology, infection disease and neurology, but we are continuously expanding our portfolio.
Diagnostics encompass a range of technologies and tools designed to detect and monitor diseases with precision.
Prognostics involve the use of advanced technologies and algorithms to predict the likely course and outcome of diseases.
Companion diagnostics are specialized tests that identify patients most likely to benefit from specific treatments, ensuring personalized and effective therapy.
Ready to Unlock you product's potential?
Schedule a demo to see how Health Economic Software can improve the market uptake of your products.
Products
Designed to help you maximize the value of your diagnostic, prognostic, or companion diagnostic product.
Medip Analytics offers a cost-effectiveness evaluation service for your diagnostic, prognostic, or companion diagnostic product across any disease area.
Our consultancy services are designed to assist companies with all health economic questions. We leverage our scientific expertise and extensive experience to advise you on your health economic strategy.
